Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-25 @ 5:36 PM
Study NCT ID:
NCT01133704
Status:
COMPLETED
Last Update Posted:
2010-09-08
First Post:
2010-05-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer
Sponsor:
Dendreon
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-05
Start Date Type:
None
Primary Completion Date:
2003-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-05
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-27
First Submit QC Date:
None
Study First Post Date:
2010-05-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-06-01
Results First Submit QC Date:
None
Results First Post Date:
2010-09-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-09-02
Last Update Post Date:
2010-09-08
Last Update Post Date Type:
ESTIMATED